Tachykinin receptors in chronic inflammatory lower airway diseases

• PENNEFATHER JN, LECCI A, LUZ CANDENAS M et al.: Tachykinins and tachykinin receptors: a growing family. Life Sci. (2004) 74:1445-1463.
   PubMed Web of Science ®Google Scholar
• ROGERS DF: Tachykinin receptor antagonists for asthma and COPD. Expert Opin. Ther. Patents (2001) 11(7):1097-1121.
   Web of Science ®Google Scholar
• WATANABE N, HORIE S, MICHAEL GJ et al.: Immunohistochemical co-localisation of transient receptor potential vanilloid (TRPV)1 and sensory neuropeptides in guinea-pig respiratory system. Neuroscience (2006) 141:1533-1543.
   PubMed Web of Science ®Google Scholar
• GRONEBERG DA, HARRISON S, DINH QT, GEPPETTI P, FISCHER A: Tachykinins in the respiratory tract. Curr. Drug Targets (2006) 7:1005-1010.
   Google Scholar
• DE SWERT K, JOOS G: Extending the understanding of sensory neuropeptides. Eur. J. Pharmacol. (2006) 533:171-181.
   Google Scholar
• TRAMONTANA M, PATACCHINI R, GIULIANI S et al.: Characterisation of the antibronchoconstrictor activity of MEN11420, a tachykinin NK2 receptor antagonist, in guinea-pigs. Eur. J. Pharmacol. (1998) 352:279-288.
   PubMedGoogle Scholar
• CORBOZ MR, FERNANDEZ X, RIZZO CA, TOZZI S, MONAHAN ME, HEY JA: Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig. Auton. Autacoid Pharmacol. (2003) 23:79-93.
   PubMedGoogle Scholar
• RICCIARDOLO FLM, RADO V, FABBRI L, STERK PJ, DI MARIA GU, GEPPETTI P: Bronchoconstriction induced by citric acid inhalation in guinea pigs. Role of tachykinins, bradykinin and nitric oxide. Am. J. Resp. Crit. Care Med. (1999) 159:557-562.
   PubMed Web of Science ®Google Scholar
• EL-HASHIM AZ, WYSS D, LEWIS C: Effect of a novel NK1 receptor selective antagonist (NKP608) on citric acid induced cough and airway obstruction. Pulm. Pharmacol. Ther. (2004) 17:11-18.
   PubMed Web of Science ®Google Scholar
• SAKAMOTO T, TSUKAGOSHI H, BARNES PJ, CHUNG KF: Involvement of tachykinin receptors (NK1 and NK2) in sodium metabisulfite-induced airway effects. Am. J. Respir. Crit. Care Med. (1994) 149:387-391.
   PubMed Web of Science ®Google Scholar
• TREVISANI M, PATACCHINI R, NICOLETTI P et al.: Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br. J. Pharmacol. (2005) 145:1123-1131.
   PubMedGoogle Scholar
• MATSUMOTO K, AIZAWA H, SHIGYO M, INOUE H, TAKATA S, HARA N: Role of tachykinins in airway narrowing induced by cigarette smoke in guinea-pigs. Environ. Toxicol. Pharmacol. (1996) 1:227-233.
   Google Scholar
• HSU TH, LAI YL, KOU YR: Acetylcholine and tachykinin receptor antagonists attenuate wood smoke-induced bronchoconstriction in guinea-pigs. Eur. J. Pharmacol. (1998) 360:175-183.
   PubMed Web of Science ®Google Scholar
• YOSHIHARA S, GEPPETTI P, HARA M et al.: Cold air-induced bronchoconstriction is mediated by tachykinin and kinin release in guinea-pigs. Eur. J. Pharmacol. (1996) 296:291-296.
   PubMed Web of Science ®Google Scholar
• SOLWAY J, KAO BM, JORDAN JE et al.: Tachykinin receptor antagonists inhibit hyperpnea-induced bronchoconstriction in guinea-pigs. J. Clin. Invest. (1993) 92:315-323.
   Google Scholar
• YANG XX, POWELL WS, HOJO M, MARTIN JG: Hyperpnea-induced bronchoconstriction is dependent on tachykinin-induced cysteinyl leukotriene synthesis. J. Appl. Physiol. (1997) 82:538-544.
   Google Scholar
• CORBOZ MR, FERNANDEZ X, HEY JA: Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on hyperventilation-induced bronchoconstriction in the guinea-pig. Pulm. Pharmacol. Ther. (2006) (In Press).
   Google Scholar
• JARREAU PH, HARF A, BOYER V, MACQUIN-MAVIER I: Aerosolized tachykinin antagonists inhibit pentamidine-induce bronchoconstriction in guinea-pigs. Fundam. Clin. Pharmacol. (1996) 10:518-523.
   Google Scholar
• FREED AN, MCCULLOCH S, MEYERS T, SUZUKI R: Neurokinins modulate hyperventilation-induced bronchoconstriction in canine peripheral airways. Am. J. Respir. Crit. Care Med. (2003) 167:1102-1108.
   Google Scholar
• GALLELLI L, D'AGOSTINO B, MARROCCO G et al.: Role of tachykinins in the bronchoconstriction induced by HCl intraesophageal instillation in the rabbit. Life Sci. (2003) 72:1135-1142.
   Google Scholar
• MONTUSCHI P, CURRÈ D, CIABATTONI G: Tachykinin NK2 receptor antagonists decrease eicosanoid release in lung anaphylaxis. Eur. J. Pharmacol. (1996) 313: R1-R3.
   Google Scholar
• KOHROGI H, YAMAGUCHI T, IWAGOE H et al.: Evidence that allergen-induced contractions of guinea-pig bronchi is mediated in part by the release of tachykinins. Int. Arch. Allergy Immunol. (1997) 112:303-308.
   PubMed Web of Science ®Google Scholar
• TANPO T, NABE T, YASUI K, KAMIKI T, KOHNO S: Participation of neuropeptides in antigen-induced contraction of guinea-pig bronchi via NK2 but not NK1 receptor stimulation. Pharmacology (2000) 60:169-174.
   PubMedGoogle Scholar
• BERTRAND C, GEPPETTI P, GRAF PD, FORESI A, NADEL JA: Involvement of neurogenic inflammation in antigen-induced bronchoconstriction in guinea-pigs. Am. J. Physiol. (1993) 265:L507-L511.
   Google Scholar
• PERRETTI F, BALLATI L, MANZINI S, MAGGI CA, EVANGELISTA S: Antibronchospastic activity of MEN10627, a novel tachykinin NK2 receptor antagonist, in guinea-pig airways. Eur. J. Pharmacol. (1995) 273:129-135.
   Google Scholar
• KRISHNAKUMAR S, HOLMES EP, MOORE RM, KAPPEL L, VENUGOPAL CS: Non-adrenergic non-cholinergic excitatory innervation in the airways: role of neurokinin-2 receptors. Auton. Autacoid Pharmacol. (2002) 22:215-224.
   Google Scholar
• WU Z-X, ZHOU D, CHEN G, LEE L-Y: Airway hyperresponsiveness to cigarette smoke in ovalbumin-sensitised guinea-pigs. Am. J. Respir. Crit. Care Med. (2000) 161:73-80.
   PubMed Web of Science ®Google Scholar
• WOISIN FE, MATSUMOTO T, DOUGLAS GJ, PAUL W, WHALLEY ET, PAGE CP: Effect of antagonists for NK2 and B22 receptors on antigen-induced airway responses in allergic rabbits. Pulmon. Pharmacol. Ther. (2000) 13:13-23.
   PubMedGoogle Scholar
• KUDLACZ EM, KNIPPENBERG RW, LOGAN DE, BURKHOLDER TP: Effect of MDL 105212, a nonpeptide NK1/NK2 receptor antagonist in an allergic guinea-pig model. J. Pharmacol. Exp. Ther. (1996) 279:732-739.
   PubMed Web of Science ®Google Scholar
• ZHANG WP, LU ZY, WEI EQ: Effects of tachykinin receptor antagonists on allergic asthma in guinea-pigs. Yao Xue Xue Bao (1997) 32:326-330.
   Google Scholar
• LILLY CM, HALL AE, RODGER IW, KOBZIK L, HALEY KJ, DRAZEN JM: Substance P-induced histamine release in tracheally perfused guinea-pig lungs. J. Appl. Physiol. (1995) 78:1234-1241.
   PubMedGoogle Scholar
• MAGHNI K, TAHA R, AFIF W, HAMID Q, MARTIN JG: Dichotomy between neurokinin receptor actions in modulating allergic airway responses in an animal model of helper T cell type 2 cytokine-associated inflammation. Am. J. Respir. Crit. Care Med. (2000) 162:1068-1074.
   PubMedGoogle Scholar
• CROSS LJ, HEANEY LG, ENNIS M: Histamine release from human bronchoalveolar lavage mast cells by neurokinin A and bradykinin. Inflamm. Res. (1997) 46:306-309.
   Google Scholar
• OSKERITZIAN CA, ZHAO W, MIN H-K et al.: Surface CD88 functionally distinguishes the MCTC from MCT type of human lung mast cell. J. Allergy Clin. Immunol. (2005) 115:1162-1168.
   PubMed Web of Science ®Google Scholar
• VERLEDEN GM, BELVISI M, RABE KF, MIURA M, BARNES PJ: β2-adrenoceptor agonists inhibit NANC neural bronchoconstrictor responses in vitro. J. Appl. Physiol. (1993) 74:1195-1199.
   PubMed Web of Science ®Google Scholar
• DAOUI S, COGNON C, NALINE E, EMONDS-ALT X, ADVENIER C: Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea-pigs. Am. J. Respir. Crit. Care Med. (1998) 158:42-48.
   PubMed Web of Science ®Google Scholar
• CANNING BJ, REYNOLDS SM, ANUKU LU, KAJEKAR R, MYERS AC: Endogenous neurokinins facilitate synaptic transmission in guinea-pig airway parasympathetic ganglia. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2002) 283:R320-R330.
   Google Scholar
• BELVISI MG, PATACCHINI R, BARNES PJ, MAGGI CA: Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences. Br. J. Pharmacol. (1994) 111:103-110.
   PubMed Web of Science ®Google Scholar
• MCALEXANDER MA, UNDEM BJ: Enhancement of tachykinin-induced contractions of guinea-pig isolated bronchus by corticotrophin-releasing factor. Neuropeptides (1997) 31:293-299.
   Google Scholar
• JOACHIM RA, SAGACH V, QUARCOO D, DINH QT, ARCK PC, KLAPP BF: Neurokinin-1 receptor mediates stress-exacerbated allergic airway inflammation and airway hyperresponsineness in mice. Psychosom. Med. (2004) 66:564-571.
   Google Scholar
• NALINE E, OLGART HOGLUND C, VINCENT F et al.: Role of tachykinin NK3 receptors in the release and effects of nerve growth factor in human isolated bronchi. Eur. J. Pharmacol. (2007) 560:206-211.
   Google Scholar
• FAISY C, NALINE E, DIEHL J-L, EMONDS-ALT X, CHINET T, ADVENIER C: In vitro sensitisation of human bronchus by β2-adrenergic agonists. Am. J. Physiol. Lung Cell Mol. Physiol. (2002) 283:L1033-L1042.
   Google Scholar
• JACOBY DB, YOST BL, ELWOOD T, FRYER AD: Effects of neurokinin receptor antagonists in virus-infected airways. Am. J. Physiol. Lung Cell Mol. Physiol. (2000) 279: L59-L65.
   Google Scholar
• WU Z-X, MAIZE DF Jr, SATTERFIELD BE, FRAZER DG, FEDAN JS, DEY RD: Role of intrinsic airway neurons in ozone-induced airway hyperesponsiveness in ferret trachea. J. Appl. Physiol. (2001) 91:371-378.
   PubMed Web of Science ®Google Scholar
• KRANEVELD AD, NIJKAMP FP, OOSTERHOUT AJ: Role of neurokinin-2 receptor in interleukin-5-induced airway hyperresponsiveness but not eosinophilia in guinea-pigs. Am. J. Respir. Crit. Care Med. (1997) 156:367-374.
   PubMedGoogle Scholar
• TERAMOTO S, TANAKA H, KANEKO S, ABE S: Neurokinin-1 receptor antagonist inhibits short term sulfuric acid-induced airway hyperresponsiveness in sensitised guinea-pigs. Int. Arch. Allergy Immunol. (2000) 121:53-56.
   PubMedGoogle Scholar
• KWONG K, WU Z-X, KASHON ML, KRAJNAK KM, WISE PM, LEE L-Y: Chronic smoking enhances tachykinin synthesis and airway responsiveness in guinea-pigs. Am. J. Respir. Cell Mol. Biol. (2001) 25:299-305.
   PubMed Web of Science ®Google Scholar
• MAREK W, POTTHAST JJ, MARCYNSKI B, BAUR X: Role of substance P and neurokinin A in toluene diisocyanate-induced increased airway responsiveness in rabbits. Lung (1996) 174:83-97.
   Google Scholar
• ELEKES K, HELYES Z, NEMETH J et al.: Role of capsaicin-sensitive afferents and sensory neuropeptidews in endotoxin-induced airway inflammation and consequent bronchial hyperreactivity in the mouse. Regul. Pept. (2007) 141:44-54.
   Google Scholar
• MIZUGUCHI M, FUJIMURA M, AMEMIYA T, NISHI K, OHKA T, MATSUDA T: Involvement of NK2 receptors rather than NK1 receptors in bronchial hyperresponsiveness induced by allergic reaction in guinea-pigs. Br. J. Pharmacol. (1996) 117:446-448.
   Google Scholar
• SCHUILING M, ZUIDHOF AB, ZAAGSMA J, MEURS H: Role of tachykinin NK1 and NK2 receptors in allergen-induced early and late asthmatic reactions, airway hyperresponsiveness, and airway inflammation in conscious unrestrained guinea-pigs. Clin. Exp. Allergy (1999) 29(Suppl. 2):48-52.
   Google Scholar
• D'AGOSTINO B, ADVENIER C, DE PALMA R et al.: The involvement of sensory neuropeptides in airway hyperresponsiveness in rabbits sensitised and challenged tp Parietaria judaica. Clin. Exp. Allergy (2002) 32:472-479.
   PubMedGoogle Scholar
• TRAMONTANA M, SANTICIOLI P, GIULIANI S et al.: Role of tachykinins in Sephadex-induced airway hyperreactivity and inflammation in guinea-pigs. Eur. J. Pharmacol. (2002) 439:149-158.
   PubMedGoogle Scholar
• MUKAIYAMA O, MORIMOTO K, NOSAKA E, TAKAHASHI S, YAMASHITA M: Involvement of enhanced neurokinin NK3 receptor expression in the severe asthma guinea-pig model. Eur. J. Pharmacol. (2004) 498:287-294.
   PubMed Web of Science ®Google Scholar
• HAY DWP, GIARDINA GAM, GRISWOLD DE et al.: Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea-pigs. J. Pharmacol. Exp. Ther. (2002) 300:314-323.
   PubMed Web of Science ®Google Scholar
• COYLE AJ, PERRETTI F, MANZINI S, IRVIN CG: Cationic protein-induced sensory nerve activation. J. Clin. Invest. (1994) 94:2301-2306.
   Google Scholar
• HEY JA, DANKO G, DEL PRADO M, CHAPMAN RW: Augmentation of neurally evoked cholinergic bronchoconstrictor responses by prejunctional NK2 receptors in the guinea-pig. J. Auton. Pharmacol. (1996) 16:41-48.
   PubMedGoogle Scholar
• MOORE KA, UNDEM BJ, WEINREICH D: Antigen inhalation unmasks NK2 tachykinin receptor-mediated responses in vagal afferents. Am. J. Respir. Crit. Care Med. (2000) 161:232-236.
   Google Scholar
• MUTOH T, BONHAM AC, JOAD JP: Substance P in the nucleus of the solitary tract augments bronchopulmonary C fiber reflex output. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2000) 279: R1215-R1223.
   Google Scholar
• MANZINI S: Bronchodilatation by tachykinins and capsaicin in the mouse main bronchus. Br. J. Pharmacol. (1992) 105:968-972.
   Google Scholar
• CANNING BJ, FISCHER A, UNDEM BJ: Pharmacological analysis of the tachykinin receptors that mediate activation of nonadrenergic, noncholinergic relaxant nerves that innervate guinea pig trachealis. J. Pharmacol. Exp. Ther. (1998) 284:370-377.
   PubMed Web of Science ®Google Scholar
• DE SWERT KO, TOURNOY KG, JOOS GF, PAUWELS RA: The role of the tachykinin NK1 receptor in airway changes in a mouse model of allergic asthma. J. Allergy Clin. Immunol. (2004) 113:1093-1099.
   Google Scholar
• MYERS AC, GOLDIE RG, HAY DWP: A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial ganglia neurons. Am. J. Respir. Crit. Care Med. (2005) 171:212-216.
   PubMed Web of Science ®Google Scholar
• IMASAKI T, KOBAYASHI H, HATAISHI R, HAYASHI I, TOMITA T, MAJIMA M: Nitric oxide is generated in smooth muscle layer by neurokinin A and counteracts constriction in guinea-pig airway. Nitric Oxide (2001) 5:465-474.
   PubMedGoogle Scholar
• RICCIARDOLO FLM, TREVISANI M, GEPPETTI P, NADEL JA, AMADESI S, BERTRAND C: Role of nitric oxide and septide-insensitive NK1 receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs. Br. J. Pharmacol. (2000) 129:915-920.
   Google Scholar
• OH EJ, MAZZONE SB, CANNING BJ, WEINREICH D: Reflex regulation of airway sympathetic nerves in guinea-pigs. J. Physiol. (2006) 573:549-564.
   Google Scholar
• RODGER IW, TOUSIGNANT C, YOUNG D, SAVOIE C, CHAN C-C: Neurokinin receptors subserving plasma extravasation in guinea-pig airways. Can. J. Physiol. Pharmacol. (1995) 73:927-931.
   Google Scholar
• FU L, KANEKO T, IKEDA H et al.: Tachykinins via tachykinin NK2 receptor activation mediate ozone-induced increase in the permeability of the tracheal mucosa in guinea-pigs. Br. J. Pharmacol. (2002) 135:1331-1335.
   PubMedGoogle Scholar
• TAGAWA A, KANEKO T, NISHIYAMA H et al.: Cigarette smoke increases mucosal permeability in guinea-pig trachea via tachykinin NK2 receptor activation. Eur. J. Pharmacol. (2005) 507:223-228.
   Google Scholar
• ISHIKAWA J, ICHINOSE M, MIURA M et al.: Involvement of endogenous tachykinins in LTD4-induced airway responses. Eur. Respir. J. (1996) 9:486-492.
   Google Scholar
• NAKAJIMA N, ICHINOSE M, TAKAHASHI T et al.: Bradykinin-induced airway inflammation. Contribution of sensory neuropeptides differs according o the airway site. Am. J. Respir. Crit. Care Med. (1994) 149:694-698.
   Google Scholar
• GREENFEDER S, SEHRING S, MCHUGH N et al.: Tryptase-induced airway microvascular leakage in guinea-pigs: involvement of tachykinins and leukotrienes. Eur. J. Pharmacol. (2001) 419:261-267.
   Google Scholar
• TAMAOKI J, YAMAWAKI I, TAIRA M, NAGANO Y, NAKATA J, NAGAI A: Effect of cromolyn on adenosine-induced airway microvascular leakage in sensitised rats. Eur. Respir. J. (1999) 14:1082-1087.
   Google Scholar
• BERTRAND C, NADEL JA, YAMAWAKI I, GEPPETTI P: Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea-pig trachea. J. Immunol. (1993) 151:4902-4907.
   PubMed Web of Science ®Google Scholar
• SENDO T, ITOH Y, GOROMARU T et al.: Role of substance P in hypersensitivity reactions induced by paclitaxel, an anticancer agent. Peptides (2004) 25:1205-1208.
   PubMed Web of Science ®Google Scholar
• EMANUELI C, GRADY EF, MADEDDU P et al.: Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P. Hypertension (1998) 31:1299-1304.
   PubMed Web of Science ®Google Scholar
• BALUK P, BERTRAND C, GEPPETTI P, MCDONALD DM, NADEL JA: NK1 receptor mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am. J. Physiol. (1995) 268:L263-L269.
   PubMed Web of Science ®Google Scholar
• AUBERSON S, LUNDBERG JM: Lactic acid-induced plasma protein extravasation in rat airways by stimulation of sensory nerves and NK1 receptor activation. Pharmacol. Toxicol. (1993) 73:305-310.
   Google Scholar
• ITO K, SAKAMOTO T, HAYASHI Y et al.: Role of tachykinin and bradykinin receptors and mast cells in gaseous formaldehyde-induced airway microvascular leakage in rats. Eur. J. Pharmacol. (1996) 307:291-298.
   PubMed Web of Science ®Google Scholar
• LIN YS, HO C-Y, TANG G-J, KOU YR: Alleviation of wood smoke-induced lung injury by tachykinin receptor antagonist and hydroxyl radical scavenger in guinea-pigs. Eur. J. Pharmacol. (2001) 425:141-148.
   PubMed Web of Science ®Google Scholar
• BALUK P, BERTRAND C, GEPPETTI P, MCDONALD DM, NADEL JA: NK1 receptor antagonist CP-99994 inhibits cigarette smoke-induced neutrophil and eosinophil adhesion in rat tracheal venules. Exp. Lung Res. (1996) 22:409-418.
   PubMed Web of Science ®Google Scholar
• HAMAMOTO J, KOHROGI H, KAWANO O et al.: Esophageal stimulation by hydrochloric acid causes neurogenic inflammation in the airways in guinea-pigs. J. Appl. Physiol. (1997) 82:738-745.
   PubMed Web of Science ®Google Scholar
• NEMMAR A, DELAUNOIS A, NEMERY B et al.: Inflammatory effect of intratracheal instillation of ultrafine particles in the rabbit: role of C-fiber and mast cells. Toxicol. Appl. Pharmacol. (1999) 160:250-261.
   PubMedGoogle Scholar
• BOZIC CR, LU B, HOPKEN UE, GERARD C, GERARD NP: Neurogenic amplification of immune complex inflammation. Science (1996) 273:1722-1725.
   PubMed Web of Science ®Google Scholar
• CHAVOLLA-CALDERON M, BAYER M, PEREZ-FONTAN JJ: Bone marrow transplantation reveals an essential synergy between neuronal and hemopoietic cell neurokinin production in pulmonary inflammation. J. Clin. Invest. (2003) 111:973-980.
   PubMed Web of Science ®Google Scholar
• KUO H-P, HWANG K-H, LIN H-C, WANG C-H, LIU C-Y, LU L-C: Lipopolysaccharide enhances neurogenic plasma exudation in guinea-pig airways. Br. J. Pharmacol. (1998) 125:711-716.
   Google Scholar
• KING KA, HU C, RODRIGUEZ MM, ROMAGUERRA R, JIANG X, PIEDIMONTE G: Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am. J. Respir. Cell Mol. Biol. (2001) 24:101-107.
   PubMedGoogle Scholar
• VERONESI B, CARTER JD, DEVLIN RB, SIMON SA, OORTGIESEN M: Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human epithelial cell line. Neuropeptides (1999) 33:447-456.
   PubMed Web of Science ®Google Scholar
• WILLIAMS R, ZOU X, HOYLE GW: Tachykinin-1 receptor stimulates proinflammatory gene expression in lung epithelial cells through activation of NF-κB via a G(q)-dependent pathway. Am. J. Physiol. Lung Cell Mol. Physiol. (2007) 292:L430-L437.
   PubMed Web of Science ®Google Scholar
• KNIGHT D, MCKAY K, WIGGS B, SHELLENBERG R, BAI T: Localization of leukaemia inhibitory factor to airway epithelium and its amplification of contractile responses to tachykinins. Br. J. Pharmacol. (1997) 120:883-891.
   Google Scholar
• BOST KL: Tachykinin-modulated anti-viral responses. Front. Biosci. (2004) 9:1994-1998.
   Google Scholar
• BLUM AM, METWALI A, ELLIOTT DE, WEINSTOCK JV: T cell substance P receptor governs antigen-elicited IFN-γ production. Am. J. Physiol. Gastrointest. Liver Physiol. (2003) 284:G197-G204.
   PubMedGoogle Scholar
• ALESSANDRI AL, PINHO V, SOUZA DG et al.: Mechanisms underlying the inhibitory effects of tachykinin receptor antagonists on eosinophil recruitment in an allergic pleurisy model in mice. Br. J. Pharmacol. (2003) 140:847-854.
   Google Scholar
• GRISSELL TV, CHANG AB, GIBSON PG: Reduced toll-like receptor 4 and substance P gene expression is associated with airway bacterial colonisation in children. Pediatr. Pulmonol. (2007) 42:380-385.
   PubMed Web of Science ®Google Scholar
• HOOD VC, CRUWYS SC, URBAN L, KIDD BL: Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis. Regul. Pept. (2000) 96:17-21.
   PubMedGoogle Scholar
• FREISTRITZER C, CLAUSEN J, STURN DH et al.: Natural killer cell functions mediated by the neuropeptide substance P. Regul. Pept. (2003) 116:119-126.
   Google Scholar
• HOSHINO H, LOTVALL J, SKOOG B-E, LINDEN A: Neutrophil recruitment by interleukin-17 into rat airway in vivo. Am. J. Respir. Crit. Care Med. (1999) 159:1423-1428.
   PubMed Web of Science ®Google Scholar
• AUAIS A, ADKINS B, NAPCHAN G, PIEDIMONTE G: Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats. Am. J. Physiol. Lung Cell Mol. Physiol. (2003) 285:105-113.
   PubMed Web of Science ®Google Scholar
• BRUNELLESCHI S, NICALI R, LAVAGNO L et al.: Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers. Neuropeptides (2000) 34:45-50.
   PubMed Web of Science ®Google Scholar
• TIBERIO IFLC, LEICK-MALDONADO EA, MIYAHARA L, KASAHARA DI, SPILBORGHS GMGT, MARTINS MA: Effects of neurokinins on airway and alveolar eosinophil recruitment. Exp. Lung Res. (2003) 29:165-177.
   PubMed Web of Science ®Google Scholar
• SCHUILING M, ZUIDHOF AB, ZAAGSMA J, MEURS H: Involvement of tachykinin NK1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammation in conscious, unrestrained guinea-pigs. Am. J. Respir. Crit. Care Med. (1999) 159:423-430.
   PubMedGoogle Scholar
• SCHUILING M, ZUIDHOF AB, MEURS H, ZAAGSMA J: Role of tachykinin NK2 receptor activation in the allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cell influx in conscious, unrestrained guinea-pigs. Br. J. Pharmacol. (1999) 127:1030-1038.
   Google Scholar
• NENAN S, GERMAIN N, LAGENTE V, EMONDS-ALT X, ADVENIER C, BOICHOT E: Inhibition of inflammatory cell recruitment by the tachykinin NK3 receptor antagonist, SR 142801, in a murine model of asthma. Eur. J. Pharmacol. (2001) 421:201-205.
   PubMed Web of Science ®Google Scholar
• KUNG TT, CRAWLEY Y, JONES H et al.: Tachykinin NK3 receptor deficiency does not inhibit pulmonary eosinophilia in allergic mice. Pharmacol. Res. (2004) 50:611-615.
   Google Scholar
• VERON M, GUENON I, NENAN S et al.: Interaction of tachykinin receptor antagonists with lipopolysaccharide-induced airway inflammation in mice. Clin. Exp. Pharmacol. Physiol. (2004) 31:634-640.
   Google Scholar
• ROBLEDO RF, WITTEN ML: NK1 receptor activation prevents hydrocarbon-induced lung injury in mice. Am. J. Physiol. (1999) 276 (2 Part 1):L229-L238.
   Google Scholar
• TAKEBAYASHI T, ABRAHAM J, MURTHY GGK, LILLY C, RODGER I, SHORE SA: Role of tachykinins in airway responses to ozone in rats. J. Appl. Physiol. (1998) 85:442-450.
   PubMed Web of Science ®Google Scholar
• MEINI S, MAK JCW, ROHDE JAL, ROGERS DF: Tachykinin control of ferret airways: mucus secretion, bronchoconstriction and receptor mapping. Neuropeptides (1993) 24:81-89.
   PubMed Web of Science ®Google Scholar
• KHAWAJA AM, LIU Y-C, ROGERS DF: Effect of non-peptide tachykinin NK1 receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea. Eur. J. Pharmacol. (1999) 384:173-181.
   Google Scholar
• KHAN S, LIU YC, KHAWAJA AM, MANZINI S, ROGERS DF: Effect of the long-acting tachykinin NK1 receptor antagonist MEN11467 on tracheal secretion in allergic ferrets. Br. J. Pharmacol. (2001) 132:189-196.
   Google Scholar
• KIM JS, RABE KF, MAGNUSSEN H, GREEN J, WHITE SR: Migration and proliferation of guinea-pig and human airway epithelial cells in response to tachykinins. Am. J. Physiol. (1995) 269 (1 Part 1):L119-L126.
   Google Scholar
• WHITE SR, GARLAND A, GITTER B et al.: Proliferation of guinea-pig tracheal epithelial cells in co-culture with rat dorsal root ganglion neural cells. Am. J. Physiol. (1995) 268 (6 Part 1):L957-L965.
   Google Scholar
• NOVERAL JP, GRUNSTEIN MM: Tachykinin regulation of airway smooth muscle cell proliferation. Am. J. Physiol. (1995) 269:L339-L343.
   PubMed Web of Science ®Google Scholar
• HARRISON NK, DAWES KE, KWON OJ, BARNES PJ, LAURENT GJ, CHUNG KF: Effects of neuropeptides on human ling fibroblast proliferation and chemotaxis. Am. J. Physiol. (1995) 268:L278-L283.
   Google Scholar
• KOHYAMA T, ERTL R, VALENTI V et al.: Prostaglandin E2 inhibits fibroblast chemotaxis. Am. J. Physiol. Lung Cell Mol. Physiol. (2001) 281:L1257-L1263.
   PubMed Web of Science ®Google Scholar
• D'ORTHO MP, JARREAU PH, DELACOURT C et al.: Tachykinins induce gelatinase production by guinea-pig macrophages: involvement of NK2 receptors. Am. J. Physiol. (1995) 269:L631-L636.
   PubMed Web of Science ®Google Scholar
• LUCATELLI M, FINESCHI S, GEPPETTI P, GERARD N, LUNGARELLA G: Neurokinin-1 receptor blockade and murine lung tumorigenesis. Am. J. Respir. Crit. Care Med. (2006) 174:674-683.
   Google Scholar
• LOSCO PE, LEACH MW, SINHA D et al.: Administration of an antagonist of neurokinin receptors 1, 2, and 3 results in reproductive tract changes in beagle dogs but not rats. Toxicol. Pathol. (2007) 35:310-322.
   Google Scholar
• JOOS GF, DE SWERT KO, PAUWELS RA: Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists. Eur. J. Pharmacol. (2001) 429:239-250.
   PubMed Web of Science ®Google Scholar
• VAN SCHOOR J, JOOS GF, PAUWELS RA: Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma. Eur. Respir. J. (2002) 19:997-1002.
   Google Scholar
• PROSPERINI G, ARCIDIACONO G, CIAMARRA I, CRIMI N, POLOSA R: Beclometasone dipropionate attenuates airways hyperresponsivenes to neurokinin A and istamine in asthma. Respir. Med. (2006) 100:1006-1012.
   Google Scholar
• JOOS G, PAUWELS R, VAN DER STRAETEN M: The effect of oxitropium bromide on neurokinin A-induced bronchoconstriction in asthmatic subjects. Pulm. Pharmacol. (1988) 1:41-45.
   PubMedGoogle Scholar
• CRIMI N, PALERMO F, OLIVIERI R et al.: Influence of antihistamine (astemizole) and anti-cholinergic drugs (ipratropium bromide) on bronchoconstriction induced by substance P. Ann. Allergy (1990) 65:115-120.
   PubMedGoogle Scholar
• CRIMI N, PALERMO F, OLIVIERI R et al.: Effect of nedocromil on bronchospasm induced by inhalation of substance P in asthmatic subjects. Clin. Allergy (1988) 18:375-382.
   PubMedGoogle Scholar
• CRIMI N, PALERMO F, OLIVIERI R et al.: Bronchospasm induced by inhalation of substance P: effect of sodium cromoglycate. Respiration (1988) 54(Suppl. 1):95-99.
   PubMedGoogle Scholar
• JOOS GF, PAUWELS RA, VAN DER STRAETEN M: Effect of nedocromil sodium on the bronchoconstrictor effect of neurokinin A in subject with asthma. J. Allergy Clin. Immunol. (1989) 83:663-668.
   PubMed Web of Science ®Google Scholar
• CRIMI N, PAGANO C, PALERMO F et al.: Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction. J. Allergy Clin. Immunol. (2003) 111:833-839.
   Google Scholar
• VAN SCHOOR J, JOOS GF, CHASSON BL, BROUARD RJ, PAUWELS RA: The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics. Eur. Respir. J. (1998) 12:17-23.
   PubMed Web of Science ®Google Scholar
• JOOS G, SCHELFHOUT V, VAN DE VELDE V, MAGGI C, PAUWELS R: The effect of the tachykinin NK2 receptor antagonist MEN11420 (nepadutant) on neurokinin A-induced bronchoconstriction in patients with asthma. Am. J. Respir. Crit. Care Med. (2001) 163(Suppl. 5):A628.
   Google Scholar
• JOOS GF, VINCKEN W, LOUIS R et al.: Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients. Eur. Respir. J. (2004) 23:76-81.
   PubMed Web of Science ®Google Scholar
• BOOT JD, DE HAAS S, TARASEVYCH S et al.: Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma. Am. J. Respir. Crit. Care Med. (2007) 175:450-457.
   PubMed Web of Science ®Google Scholar
• SCHELFHOUT V, LOUIS R, LENZ W, HEYRMAN R, PAUWELS R, JOOS G: The triple neurokinin receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma. Pulm. Pharmacol. Ther. (2006) 19:413-418.
   PubMed Web of Science ®Google Scholar
• CRUMMY F, LIVINGSTON M, ARDILL JES, ADAMSON C, ENNIS M, HEANEY LG: Endobronchial adenosine monophosphate challenge causes tachykinin release in the human airway. J. Allergy Clin. Immunol. (2005) 116:312-317.
   Google Scholar
• MOSIMANN BL, WHITE MV, HOHMAN RJ, GOLDRICH MS, KAULBACH HC, KALINER MA: Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J. Allergy Clin. Immunol. (1993) 92:95-104.
   PubMed Web of Science ®Google Scholar
• DIAMANT Z, VAN DER VEEN H, KUIJPERS EA, BAKKER PF, STERK PJ: The effect of inhaled tiorphan on allergen-induced airway responses in asthmatic subjects. Clin. Exp. Allergy (1996) 26:525-532.
   PubMedGoogle Scholar
• KRAAN J, VINK-KLOOSTER H, POSTMA DS: The NK2 receptor antagonist SR 48968C does not improve adenosine hyperresponsiveness and airway obstruction in allergic asthma. Clin. Exp. Allergy (2001) 31:274-278.
   PubMed Web of Science ®Google Scholar
• SCHOLZEN TE, STEINHOFF M, SINDRILARU A et al.: Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage. FASEB J. (2004) 18:1007-1009.
   Google Scholar
• LEIGH R, VETHANAYAGAM D, YOSHIDA M et al.: Effects of montelukast and budesonide on airway responses and airway inflammation in asthma. Am. J. Respir. Crit. Care Med. (2002) 166:1212-1217.
   PubMed Web of Science ®Google Scholar
• DUONG ML, GAUVREAU G, WATSON R et al.: The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge. J. Allergy Clin. Immunol. (2007) 119:322-327.
   PubMed Web of Science ®Google Scholar
• BOSCHETTO P, MIOTTO D, BONONI I et al.: Sputum substance P and neurokinin A are reduced durino exacerbations of chronic obstructive pulmonary disease. Pulm. Pharmacol. Ther. (2005) 18:199-205.
   PubMed Web of Science ®Google Scholar
• PATTERSON RN, JOHNSTON BT, ARDILL JE, HEANEY LG, MCGARVEY LP: Increased tachykinin levels in induced sputum from asthmatics and cough patients with acid reflux. Thorax (2007) 62(6):491-495.
   Google Scholar
• GIARDINA GAM, SARAU HM, FARINA C et al.: Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinoline carboxamide framework. J. Med. Chem. (1997) 40(12):1794-1807.
   PubMed Web of Science ®Google Scholar
• EMONDS-ALT X, ADVENIER C, COGNON C et al.: Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist. Neuropeptides (1997) 31(5):449-458.
   PubMed Web of Science ®Google Scholar
• NISHI T, FUKAZAWA T, ISHIBASHI K et al.: Combined NK1 and NK2 tachykinin receptor antagonists: synthesis and structure–activity relationships of novel oxazolidine analogues. Bioorg. Med. Chem. Lett. (1999) 9(6):875-880.
   PubMed Web of Science ®Google Scholar
• NISHI T, ISHIBASHI K, TAKEMOTO T et al.: Combined tachykinin receptor antagonist: synthesis and stereochemical structure (2013) activity relationships of novel morpholine analogues. Bioorg. Med. Chem. Lett. (2000) 10(15):1665-1668.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO T, IIDA M, ISHIDA K, SAKITAMA K, NISHIKAWA K: NK5807, a novel non-peptide antagonist of tachykinin NK2 receptor. Jpn. J. Pharmacol. (2001) 85(Suppl. 1):P200.
   Google Scholar
• IIDA M, MATSUMOTO T, ISHIDA K, SAKITAMA K, NISHIKAWA K: The effects of NK5807, a novel NK2 receptor antagonist, on animal model of asthma. Jpn. J. Pharmacol. (2001) 85(Suppl. 1):P197.
   Google Scholar
• D'AGOSTINO B, ADVENIER C, FALCIANI M et al.: Endothelin-1 increases cholinergic nerve-mediated contraction of human bronchi via tachykinin synthesis induction. Br. J. Pharmacol. (2001) 134:1447-1454.
   Google Scholar
• CHANEZ P, SPRINGALL D, VIGNOLA AM et al.: Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases. Am. J. Respir. Crit. Care Med. (1998) 158:985-990.
   PubMedGoogle Scholar
• HONDA I, KOHOROGI H, YAMAGUCHI T, ANDO M, ARAKI S: Enkephalinase inhibitor potentiates substance P- and capsaicin-induced bronchial smooth muscle contractions in humans. Am. Rev. Respir. Dis. (1991) 143:1416-1418.
   Google Scholar
• JARMAN ER, LAMB JR: Chronic models of airway inflammation, mucus hypersecretion and remodelling. Drug Discov. Today Dis. Models (2005) 2:119-126.
   Google Scholar

Patents

• SMITHKLINE BEECHAM CO.: WO2002040023 (2002).
   Google Scholar
• GLAXOSMITHKLINE SPA: WO2002083663 (2002).
   Google Scholar
• GLAXOSMITHKLINE SPA: WO2002044155 (2002).
   Google Scholar
• GLAXOSMITHKLINE SPA: WO2002038547 (2002).
   Google Scholar
• GLAXOSMITHKLINE SPA: WO2002038548 (2002).
   Google Scholar
• GLAXOSMITHKLINE SPA: WO2002083645 (2002).
   Google Scholar
• GLAXOSMITHKLINE SPA: WO2002044154 (2002).
   Google Scholar
• GLAXOSMITHKLINE SPA: WO2002083664 (2002).
   Google Scholar
• SMITHKLINE BEECHAM CO.: WO2005000247 (2005).
   Google Scholar
• SMITHKLINE BEECHAM CO.: WO2004066950 (2004).
   Google Scholar
• SMITHKLINE BEECHAM CO.: WO2004066951 (2004).
   Google Scholar
• MERCK SHARP & DOHME LTD.: WO2004072045 (2004).
   Google Scholar
• NIKEM RESEARCH SRL: WO2005000247 (2005).
   Google Scholar
• ASTRAZENECA AB: WO2007035157 (2007).
   Google Scholar
• ASTRAZENECA AB: WO2006137789 (2006).
   Google Scholar
• ASTRAZENECA AB: WO2007035156 (2007).
   Google Scholar
• ASTRAZENECA AB: WO2007018466 (2007).
   Google Scholar
• ASTRAZENECA AB: WO2007018465 (2007).
   Google Scholar
• ASTRAZENECA AB: WO2007018469 (2007).
   Google Scholar
• SANOFI-SYNTHELABO: WO2002094821 (2002).
   Google Scholar
• ASTRAZENECA AB: WO2004110344 (2004).
   Google Scholar
• H LUNDBECK A/S: WO2005016884 (2005).
   Google Scholar
• PFIZER, INC.: WO2003051868 (2003).
   Google Scholar
• SANKYO CO. LTD: JP2002316987 (2002).
   Google Scholar
• SANKYO CO. LTD: WO2005004875 (2005).
   Google Scholar
• SANKYO CO. LTD: WO2005054252 (2005).
   Google Scholar
• SANKYO CO. LTD: EP1746095 (2007).
   Google Scholar
• ZERIA PHARMACEUTICAL CO. LTD: EP1650189 (2006).
   Google Scholar
• NIPPON KAYAKU CO. LTD: JP2002088081 (2002).
   Google Scholar
• MERCK & CO., INC.: WO2006057921 (2006).
   Google Scholar
• MERCK & CO., INC.: WO0206057977 (2006).
   Google Scholar
• MERCK SHARP & DOHME LTD: WO2002057250 (2002).
   Google Scholar
• MERCK SHARP & DOHME LTD: WO2004078750 (2004).
   Google Scholar
• MERCK & CO., INC.: WO2006060344 (2006).
   Google Scholar
• MERCK & CO., INC.: WO2006060346 (2006).
   Google Scholar
• TANABE SEIYAKU CO. LTD: EP1693367 (2006).
   Google Scholar
• TANABE SEIYAKU CO. LTD: JP05154381 (2005).
   Google Scholar
• TANABE SEIYAKU CO. LTD: JP05154380 (2005).
   Google Scholar
• NOVARTIS AG: WO2004024714 (2004).
   Google Scholar
• SCHERING CO.: WO2003051840 (2003).
   Google Scholar
• SCHERING CO.: WO2006007540 (2006).
   Google Scholar
• SCHERING CO.: WO2004004722 (2004).
   Google Scholar
• SCHERING CO.: WO2005100358 (2005).
   Google Scholar
• SCHERING CO.: WO2006065654 (2006).
   Google Scholar
• TAKEDA CHEMICAL INDUSTRIES LTD: EP1553084 (2005).
   Google Scholar
• TAKEDA CHEMICAL INDUSTRIES LTD: EP1705176 (2006).
   Google Scholar
• TAKEDA CHEMICAL INDUSTRIES LTD: EP1460062 (2004).
   Google Scholar
• BOEHRINGER INGELHEIM PHARMA KG: WO2002032866 (2002).
   Google Scholar
• BOEHRINGER INGELHEIM PHARMA KG: WO2002032865 (2002).
   Google Scholar
• JANSSEN PHARMACEUTICA NV: WO2005097794 (2005).
   Google Scholar
• JANSSEN PHARMACEUTICA NV: WO2005097795 (2005).
   Google Scholar
• FUJISAWA PHARM & CO.:WO2004111000 (2004).
   Google Scholar
• JANSSEN PHARMACEUTICA NV: WO2004056800 (2004).
   Google Scholar
• JANSSEN PHARMACEUTICA NV: WO2004056799 (2004).
   Google Scholar
• JANSSEN PHARMACEUTICA NV: WO2004056364 (2004).
   Google Scholar
• JANSSEN PHARMACEUTICA NV: WO2004056805 (2004).
   Google Scholar
• JANSSEN PHARMACEUTICA NV: WO2005097774 (2005).
   Google Scholar
• SOLVAY PHARMACEUTICALS BV: WO2003006459 (2003).
   Google Scholar
• SOLVAY PHARMACEUTICALS BV: WO2003084955 (2003).
   Google Scholar
• SOLVAY PHARMACEUTICALS BV: WO2005030214 (2005).
   Google Scholar
• MYRIAD GENETICS, INC.: WO2004035587 (2004).
   Google Scholar
• FUJISAWA PHARM. & CO.: WO2002000632 (2002).
   Google Scholar
• FUJISAWA PHARM. & CO.: WO2002055518 (2002).
   Google Scholar
• FUJISAWA PHARM. & CO.: WO2003053957 (2003).
   Google Scholar
• HOFFMANN-LA ROCHE AG: WO2002008232 (2002).
   Google Scholar
• HOFFMANN-LA ROCHE AG: WO2002016324 (2002).
   Google Scholar
• HOFFMANN-LA ROCHE AG: WO2003011860 (2003).
   Google Scholar
• HOFFMANN-LA ROCHE AG: WO2006089658 (2006).
   Google Scholar
• MERCK & CO., INC.: WO2006060390 (2006).
   Google Scholar
• KYORIN PHARMACEUTICAL CO. LTD: EP1457493 (2004).
   Google Scholar
• KYORIN PHARMACEUTICAL CO. LTD: EP1489083 (2004).
   Google Scholar
• KYORIN PHARMACEUTICAL CO. LTD: JP2003277384 (2003).
   Google Scholar
• KYORIN PHARMACEUTICAL CO. LTD: EP1473295 (2004).
   Google Scholar
• KYORIN PHARMACEUTICAL CO. LTD: EP1496059 (2005).
   Google Scholar
• TAKEDA CHEMICAL INDUSTRIES LTD: WO2002022574 (2002).
   Google Scholar
• TAKEDA CHEMICAL INDUSTRIES LTD: WO2002074771 (2002).
   Google Scholar
• TAKEDA CHEMICAL INDUSTRIES LTD: EP1352659 (2003).
   Google Scholar
• MENARINI RICERCHE SPA & BERLIN CHEMIE AG: EP1297826 (2003).
   Google Scholar
• MENARINI RICERCHE SPA: WO2002020437 (2002).
   Google Scholar
• MENARINI RICERCHE SPA: WO2003037916 (2003).
   Google Scholar
• MENARINI RICERCHE SPA: WO2004094412 (2004).
   Google Scholar
• ASTRAZENECA AB: WO2002051807 (2002).
   Google Scholar
• ASTRAZENECA AB: WO2002012168 (2002).
   Google Scholar
• ELI LILLY & CO.: WO2003091226 (2003).
   Google Scholar
• ELI LILLY & CO.: WO2003091227 (2003).
   Google Scholar
• NEUROGEN CO.: WO2005061462 (2005).
   Google Scholar
• NEUROGEN CO.: WO2005066137 (2005).
   Google Scholar
• PREDIX PHARMACEUTICALS HOLDINGS, INC.: WO2004014850 (2004).
   Google Scholar
• PREDIX PHARMACEUTICALS HOLDINGS, INC.: WO2004030629 (2004).
   Google Scholar
• KYOWA HAKKO KOGYO CO. LTD: WO2005011674 (2004).
   Google Scholar

Websites

• http://www.ginasthma.com GINA: Global Initiative for Asthma. Global strategy for asthma management and prevention (Report updated 2006).
   Google Scholar
• http://www.goldcopd.com GOLD: Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis management and prevention of for chronic obstructive lung disease (Report updated 2006).
   Google Scholar
• http://www.iddb3.com/iddb3/iddb3_2/reports.display?id=4471&template=Drug&i_query_id=8490318 Iddb. The Investigational Drugs database. Drug report on saredutant.
   Google Scholar